Search

Your search keyword '"Klein, Nicola P."' showing total 1,199 results
Start Over Author "Klein, Nicola P."
1,199 results on '"Klein, Nicola P."'

103. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Ferdinands, Jill M., Rao, Suchitra, Dixon, Brian E., Mitchell, Patrick K., DeSilva, Malini B., Irving, Stephanie A., Lewis, Ned, Natarajan, Karthik, Stenehjem, Edward, Grannis, Shaun J., Han, Jungmi, McEvoy, Charlene, Ong, Toan C., Naleway, Allison L., Reese, Sarah E., Embi, Peter J., Dascomb, Kristin, Klein, Nicola P., Griggs, Eric P., Konatham, Deepika, Kharbanda, Anupam B., Yang, Duck-Hye, Fadel, William F., Grisel, Nancy, Goddard, Kristin, Patel, Palak, Liao, I-Chia, Birch, Rebecca, Valvi, Nimish R., Reynolds, Sue, Arndorfer, Julie, Zerbo, Ousseny, Murthy, Monica Dickerson Kempapura, Williams, Jeremiah, Bozio, Catherine H., Blanton, Lenee, Verani, Jennifer R., Schrag, Stephanie J., Dalton, Alexandra F., Wondimu, Mehiret H., Link-Gelles, Ruth, Azziz-Baumgartner, Eduardo, Barron, Michelle A., Gaglani, Manjusha, Thompson, Mark G., and Fireman, Bruce

Subjects
Pfizer Inc., Vaccination, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health
Abstract

On February 11, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). CDC recommends that all persons aged [greater than or equal to] 12 [...]

Published
2022

104. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19--Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Thompson, Mark G., Natarajan, Karthik, Irving, Stephanie A., Rowley, Elizabeth A., Griggs, Eric P., Gaglani, Manjusha, Klein, Nicola P., Grannis, Shaun J., DeSilva, Malini B., Stenehjem, Edward, Reese, Sarah E., Dickerson, Monica, Naleway, Allison L., Han, Jungmi, Konatham, Deepika, McEvoy, Charlene, Rao, Suchitra, Dixon, Brian E., Dascomb, Kristin, Lewis, Ned, Levy, Matthew E., Patel, Palak, Liao, I-Chia, Kharbanda, Anupam B., Barron, Michelle A., Fadel, William F., Grisel, Nancy, Goddard, Kristin, Yang, Duck-Hye, Wondimu, Mehiret H., Murthy, Kempapura, Valvi, Nimish R., Arndorfer, Julie, Fireman, Bruce, Dunne, Margaret M., Embi, Peter, Azziz-Baumgartner, Eduardo, Zerbo, Ousseny, Bozio, Catherine H., Reynolds, Sue, Ferdinands, Jill, Williams, Jeremiah, Link-Gelles, Ruth, Schrag, Stephanie J., Verani, Jennifer R., Ball, Sarah, and Ong, Toan C.

Subjects
Pfizer Inc., Medical research, Medicine, Experimental, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health, University of Colorado, Comirnaty (Vaccine)
Abstract

On January 21, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Estimates of COVID-19 mRNA vaccine effectiveness (VE) have declined in recent months [...]

Published
2022

105. Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022

Author

DeSilva, Malini B, primary, Mitchell, Patrick K, additional, Klein, Nicola P, additional, Dixon, Brian E, additional, Tenforde, Mark W, additional, Thompson, Mark G, additional, Naleway, Allison L, additional, Grannis, Shaun J, additional, Ong, Toan C, additional, Natarajan, Karthik, additional, Reese, Sarah E, additional, Zerbo, Ousseny, additional, Kharbanda, Anupam B, additional, Patel, Palak, additional, Stenehjem, Edward, additional, Raiyani, Chandni, additional, Irving, Stephanie A, additional, Fadel, William F, additional, Rao, Suchitra, additional, Han, Jungmi, additional, Reynolds, Sue, additional, Davis, Jonathan M, additional, Lewis, Ned, additional, McEvoy, Charlene, additional, Dickerson, Monica, additional, Dascomb, Kristin, additional, Valvi, Nimish R, additional, Barron, Michelle A, additional, Goddard, Kristin, additional, Vazquez-Benitez, Gabriela, additional, Grisel, Nancy, additional, Mamawala, Mufaddal, additional, Embi, Peter J, additional, Fireman, Bruce, additional, Essien, Inih J, additional, Griggs, Eric P, additional, Arndorfer, Julie, additional, and Gaglani, Manjusha, additional

Published
2022
Full Text
View/download PDF

108. Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

Author

Embi, Peter J., primary, Levy, Matthew E., additional, Patel, Palak, additional, DeSilva, Malini B., additional, Gaglani, Manjusha, additional, Dascomb, Kristin, additional, Dunne, Margaret M., additional, Klein, Nicola P., additional, Ong, Toan C., additional, Grannis, Shaun J., additional, Natarajan, Karthik, additional, Yang, Duck-Hye, additional, Stenehjem, Edward, additional, Zerbo, Ousseny, additional, McEvoy, Charlene, additional, Rao, Suchitra, additional, Thompson, Mark G., additional, Konatham, Deepika, additional, Irving, Stephanie A., additional, Dixon, Brian E., additional, Han, Jungmi, additional, Schrader, Kristin E., additional, Grisel, Nancy, additional, Lewis, Ned, additional, Kharbanda, Anupam B., additional, Barron, Michelle A., additional, Reynolds, Sue, additional, Liao, I-Chia, additional, Fadel, William F., additional, Rowley, Elizabeth A., additional, Arndorfer, Julie, additional, Goddard, Kristin, additional, Murthy, Kempapura, additional, Valvi, Nimish R., additional, Weber, Zachary A., additional, Fireman, Bruce, additional, Reese, Sarah E., additional, Ball, Sarah W., additional, and Naleway, Allison L., additional

Published
2022
Full Text
View/download PDF

109. Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods

Author

Link-Gelles, Ruth, primary, Levy, Matthew E., additional, Natarajan, Karthik, additional, Reese, Sarah E., additional, Naleway, Allison L., additional, Grannis, Shaun J., additional, Klein, Nicola P., additional, DeSilva, Malini B., additional, Ong, Toan C., additional, Gaglani, Manjusha, additional, Hartmann, Emily, additional, Dickerson, Monica, additional, Stenehjem, Edward, additional, Kharbanda, Anupam B., additional, Han, Jungmi, additional, Spark, Talia L., additional, Irving, Stephanie A., additional, Dixon, Brian E., additional, Zerbo, Ousseny, additional, McEvoy, Charlene E., additional, Rao, Suchitra, additional, Raiyani, Chandni, additional, Sloan-Aagard, Chantel, additional, Patel, Palak, additional, Dascomb, Kristin, additional, Uhlemann, Anne-Catrin, additional, Dunne, Margaret M., additional, Fadel, William F., additional, Lewis, Ned, additional, Barron, Michelle A., additional, Murthy, Kempapura, additional, Nanez, Juan, additional, Griggs, Eric P., additional, Grisel, Nancy, additional, Annavajhala, Medini K., additional, Akinseye, Akintunde, additional, Valvi, Nimish R., additional, Goddard, Kristin, additional, Mamawala, Mufaddal, additional, Arndorfer, Julie, additional, Yang, Duck-Hye, additional, Embí, Peter J., additional, Fireman, Bruce, additional, Ball, Sarah W., additional, and Tenforde, Mark W., additional

Published
2022
Full Text
View/download PDF

110. Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data

Author

Nelson, Jennifer C, primary, Ulloa-Pérez, Ernesto, additional, Yu, Onchee, additional, Cook, Andrea J, additional, Jackson, Michael L, additional, Belongia, Edward A, additional, Daley, Matthew F, additional, Harpaz, Rafael, additional, Kharbanda, Elyse O, additional, Klein, Nicola P, additional, Naleway, Allison L, additional, Tseng, Hung-Fu, additional, Weintraub, Eric S, additional, Duffy, Jonathan, additional, Yih, W Katherine, additional, and Jackson, Lisa A, additional

Published
2022
Full Text
View/download PDF

111. Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

Author

Ferdinands, Jill M, primary, Rao, Suchitra, additional, Dixon, Brian E, additional, Mitchell, Patrick K, additional, DeSilva, Malini B, additional, Irving, Stephanie A, additional, Lewis, Ned, additional, Natarajan, Karthik, additional, Stenehjem, Edward, additional, Grannis, Shaun J, additional, Han, Jungmi, additional, McEvoy, Charlene, additional, Ong, Toan C, additional, Naleway, Allison L, additional, Reese, Sarah E, additional, Embi, Peter J, additional, Dascomb, Kristin, additional, Klein, Nicola P, additional, Griggs, Eric P, additional, Liao, I-Chia, additional, Yang, Duck-Hye, additional, Fadel, William F, additional, Grisel, Nancy, additional, Goddard, Kristin, additional, Patel, Palak, additional, Murthy, Kempapura, additional, Birch, Rebecca, additional, Valvi, Nimish R, additional, Arndorfer, Julie, additional, Zerbo, Ousseny, additional, Dickerson, Monica, additional, Raiyani, Chandni, additional, Williams, Jeremiah, additional, Bozio, Catherine H, additional, Blanton, Lenee, additional, Link-Gelles, Ruth, additional, Barron, Michelle A, additional, Gaglani, Manjusha, additional, Thompson, Mark G, additional, and Fireman, Bruce, additional

Published
2022
Full Text
View/download PDF

112. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

Author

Schrag, Stephanie J., primary, Verani, Jennifer R., additional, Dixon, Brian E., additional, Page, Jessica M., additional, Butterfield, Kristen A., additional, Gaglani, Manjusha, additional, Vazquez-Benitez, Gabriela, additional, Zerbo, Ousseny, additional, Natarajan, Karthik, additional, Ong, Toan C., additional, Lazariu, Victoria, additional, Rao, Suchitra, additional, Beaver, Ryan, additional, Ellington, Sascha R., additional, Klein, Nicola P., additional, Irving, Stephanie A., additional, Grannis, Shaun J., additional, Kiduko, Salome, additional, Barron, Michelle A., additional, Midturi, John, additional, Dickerson, Monica, additional, Lewis, Ned, additional, Stockwell, Melissa S., additional, Stenehjem, Edward, additional, Fadel, William F., additional, Link-Gelles, Ruth, additional, Murthy, Kempapura, additional, Goddard, Kristin, additional, Grisel, Nancy, additional, Valvi, Nimish R., additional, Fireman, Bruce, additional, Arndorfer, Julie, additional, Konatham, Deepika, additional, Ball, Sarah, additional, Thompson, Mark G., additional, and Naleway, Allison L., additional

Published
2022
Full Text
View/download PDF

115. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults--Nine States, January-September 2021

Author

Embi, Peter J., Levy, Matthew E., Naleway, Allison L., Patel, Palak, Gaglani, Manjusha, Natarajan, Karthik, Dascomb, Kristin, Ong, Toan C., Klein, Nicola P., Liao, I.-Chia, Grannis, Shaun J., Han, Jungmi, Stenehjem, Edward, Dunne, Margaret M., Lewis, Ned, Irving, Stephanie A., Rao, Suchitra, McEvoy, Charlene, Bozio, Catherine H., Murthy, Kempapura, Dixon, Brian E., Grisel, Nancy, Yang, Duck-Hye, Goddard, Kristin, Kharbanda, Anupam B., Reynolds, Sue, Raiyani, Chandni, Fadel, William F., Arndorfer, Julie, Rowley, Elizabeth A., Fireman, Bruce, Ferdinands, Jill, Valvi, Nimish R., Ball, Sarah W., Zerbo, Ousseny, Griggs, Eric P., Mitchell, Patrick K., Porter, Rachael M., Kiduko, Salome A., Blanton, Lenee, Zhuang, Yan, Steffens, Andrea, Reese, Sarah E., Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle A., Thompson, Mark G., and DeSilva, Malini B.

Subjects
Pfizer Inc., Vaccination, Messenger RNA, Adults, Pharmaceutical industry, Health
Abstract

On November 2, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Immunocompromised persons, defined as those with suppressed humoral or cellular immunity resulting [...]

Published
2021

116. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity--Nine States, January-September 2021

Author

Bozio, Catherine H., Grannis, Shaun J., Naleway, Allison L., Ong, Toan C., Butterfield, Kristen A., DeSilva, Malini B., Natarajan, Karthik, Yang, Duck-Hye, Rao, Suchitra, Klein, Nicola P., Irving, Stephanie A., Dixon, Brian E., Dascomb, Kristin, Liao, I.-Chia, Reynolds, Sue, McEvoy, Charlene, Han, Jungmi, Reese, Sarah E., Lewis, Ned, Fadel, William F., Grisel, Nancy, Murthy, Kempapura, Ferdinands, Jill, Kharbanda, Anupam B., Mitchell, Patrick K., Goddard, Kristin, Embi, Peter J., Arndorfer, Julie, Raiyani, Chandni, Patel, Palak, Rowley, Elizabeth A., Fireman, Bruce, Valvi, Nimish R., Griggs, Eric P., Levy, Matthew E., Zerbo, Ousseny, Porter, Rachael M., Birch, Rebecca J., Blanton, Lenee, Ball, Sarah W., Steffens, Andrea, Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle, Gaglani, Manjusha, Thompson, Mark G., and Stenehjem, Edward

Subjects
Pfizer Inc., Vaccination -- Health aspects, Messenger RNA -- Health aspects, Infection -- Health aspects, Adults -- Health aspects, Vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, Health
Abstract

On October 29, 2021 this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination [...]

Published
2021

117. COVID-19 Vaccination and Non-COVID-19 Mortality Risk--Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021

Author

Xu, Stanley, Huang, Runxin, Sy, Lina S., Glenn, Sungching C., Ryan, Denison S., Morrissette, Kerresa, Shay, David K., Vazquez-Benitez, Gabriela, Glanz, Jason M., Klein, Nicola P., McClure, David, Liles, Elizabeth G., Weintraub, Eric S., Tseng, Hung-Fu, and Qian, Lei

Subjects
Pfizer Inc. -- Reports, Vaccination -- Health aspects -- Reports, Mortality -- United States, RNA -- Health aspects -- Reports, Evidence-based medicine -- Health aspects -- Reports, Pharmaceutical industry -- Health aspects -- Reports, Health, Kaiser Permanente -- Reports
Abstract

On October 22, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). By September 21, 2021, an estimated 182 million persons in the United [...]

Published
2021

123. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices--United States, July 2021

Author

Rosenblum, Hannah G., Hadler, Stephen C., Moulia, Danielle, Shimabukuro, Tom T., Su, John R., Tepper, Naomi K., Ess, Kevin C., Woo, Emily Jane, Mba-Jonas, Adamma, Alimchandani, Meghna, Nair, Narayan, Klein, Nicola P., Hanson, Kayla E., Markowitz, Lauri E., Wharton, Melinda, McNally, Veronica V., Romero, Jose R., Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., Mbaeyi, Sarah A., and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, Johnson & Johnson, Pfizer Inc., Messenger RNA -- Usage, Adults -- Usage, Vaccines -- Usage -- Complications and side effects, Pharmaceutical industry -- Usage, Health
Abstract

On August 10, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). In December 2020, the Food and Drug Administration (FDA) issued Emergency Use [...]

Published
2021

124. COVID-19 Vaccination Coverage Among Insured Persons Aged [greater than or equal to] 16 Years, by Race/Ethnicity and Other Selected Characteristics--Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021

Author

Pingali, Cassandra, Meghani, Mehreen, Razzaghi, Hilda, Lamias, Mark J., Weintraub, Eric, Kenigsberg, TatYana A., Klein, Nicola P., Lewis, Ned, Fireman, Bruce, Zerbo, Ousseny, Bartlett, Joan, Goddard, Kristin, Donahue, James, Hanson, Kayla, Naleway, Allison, Kharbanda, Elyse O., Yih, W.Katherine, Nelson, Jennifer Clark, Lewin, Bruno J., Williams, Joshua T.B., Glanz, Jason M., Singleton, James A., and Patel, Suchita A.

Subjects
Pfizer Inc., Vaccination, Pharmaceutical industry, Health
Abstract

COVID-19 vaccination is critical to ending the COVID-19 pandemic. Members of minority racial and ethnic groups have experienced disproportionate COVID-19--associated morbidity and mortality (1); however, COVID-19 vaccination coverage is lower [...]

Published
2021

125. Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination

Author

Goddard, Kristin, primary, Lewis, Ned, additional, Fireman, Bruce, additional, Weintraub, Eric, additional, Shimabukuro, Tom, additional, Zerbo, Ousseny, additional, Boyce, Thomas G., additional, Oster, Matthew E., additional, Hanson, Kayla E., additional, Donahue, James G., additional, Ross, Pat, additional, Naleway, Allison, additional, Nelson, Jennifer C., additional, Lewin, Bruno, additional, Glanz, Jason M., additional, Williams, Joshua T.B., additional, Kharbanda, Elyse O., additional, Katherine Yih, W., additional, and Klein, Nicola P., additional

Published
2022
Full Text
View/download PDF

126. Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years

Author

Hause, Anne M., primary, Shay, David K., additional, Klein, Nicola P., additional, Abara, Winston E., additional, Baggs, James, additional, Cortese, Margaret M., additional, Fireman, Bruce, additional, Gee, Julianne, additional, Glanz, Jason M., additional, Goddard, Kristin, additional, Hanson, Kayla E., additional, Hugueley, Brandon, additional, Kenigsberg, Tat’Yana, additional, Kharbanda, Elyse O., additional, Lewin, Bruno, additional, Lewis, Ned, additional, Marquez, Paige, additional, Myers, Tanya, additional, Naleway, Allison, additional, Nelson, Jennifer C., additional, Su, John R., additional, Thompson, Deborah, additional, Olubajo, Babatunde, additional, Oster, Matthew E., additional, Weintraub, Eric S., additional, Williams, Joshua T.B., additional, Yousaf, Anna R., additional, Zerbo, Ousseny, additional, Zhang, Bicheng, additional, and Shimabukuro, Tom T., additional

Published
2022
Full Text
View/download PDF

128. Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination of Black and Latino Older Adults

Author

Lieu, Tracy A., primary, Elkin, Eric P., additional, Escobar, Patricia R., additional, Finn, Lucy, additional, Klein, Nicola P., additional, Durojaiye, Cimone, additional, Prausnitz, Stephanie, additional, Quesenberry, Charles P., additional, Sawyer, Debora, additional, Teran, Silvia, additional, Goler, Nancy, additional, Parodi, Stephen M., additional, and Chen, Yi-Fen Irene, additional

Published
2022
Full Text
View/download PDF

129. Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero

Author

Zerbo, Ousseny, primary, Modaressi, Sharareh, additional, Goddard, Kristin, additional, Lewis, Edwin, additional, Getahun, Darios, additional, Palmsten, Kristin K., additional, Fuller, Candace C., additional, Crane, Bradley, additional, Donahue, James G., additional, Daley, Matthew F., additional, Jackson, Lisa A., additional, Wodi, A. Patricia, additional, McNeil, Michael M., additional, and Klein, Nicola P., additional

Published
2022
Full Text
View/download PDF

130. Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons

Author

Daley, Matthew F., primary, Reifler, Liza M., additional, Shoup, Jo Ann, additional, Glanz, Jason M., additional, Naleway, Allison L., additional, Jackson, Michael L., additional, Hambidge, Simon J., additional, McLean, Huong, additional, Kharbanda, Elyse O., additional, Klein, Nicola P., additional, Lewin, Bruno J., additional, Weintraub, Eric S., additional, McNeil, Michael M., additional, Razzaghi, Hilda, additional, and Singleton, James A., additional

Published
2022
Full Text
View/download PDF

131. Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

Author

Langley, Joanne M, primary, Bianco, Veronique, additional, Domachowske, Joseph B, additional, Madhi, Shabir A, additional, Stoszek, Sonia K, additional, Zaman, Khalequ, additional, Bueso, Agustin, additional, Ceballos, Ana, additional, Cousin, Luis, additional, D’Andrea, Ulises, additional, Dieussaert, Ilse, additional, Englund, Janet A, additional, Gandhi, Sanjay, additional, Gruselle, Olivier, additional, Haars, Gerco, additional, Jose, Lisa, additional, Klein, Nicola P, additional, Leach, Amanda, additional, Maleux, Koen, additional, Nguyen, Thi Lien Anh, additional, Puthanakit, Thanyawee, additional, Silas, Peter, additional, Tangsathapornpong, Auchara, additional, Teeratakulpisarn, Jamaree, additional, Vesikari, Timo, additional, and Cohen, Rachel A, additional

Published
2022
Full Text
View/download PDF

138. Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial

Author

Jain, Varsha K., Domachowske, Joseph B., Wang, Long, Ofori-Anyinam, Opokua, Rodríguez-Weber, Miguel A., Leonardi, Michael L., Klein, Nicola P., Schlichter, Gary, Jeanfreau, Robert, Haney, Byron L., Chu, Laurence, Harris, Jo-Ann S., Sarpong, Kwabena O., Micucio, Amanda C., Soni, Jyoti, Chandrasekaran, Vijayalakshmi, Li, Ping, and Innis, Bruce L.

Published
2017
Full Text
View/download PDF

140. Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons.

Author

Daley, Matthew F., Reifler, Liza M., Shoup, Jo Ann, Glanz, Jason M., Naleway, Allison L., Jackson, Michael L., Hambidge, Simon J., McLean, Huong, Kharbanda, Elyse O., Klein, Nicola P., Lewin, Bruno J., Weintraub, Eric S., McNeil, Michael M., Razzaghi, Hilda, and Singleton, James A.

Subjects
INFLUENZA vaccines, IMMUNIZATION, CONFIDENCE intervals, PREDICTIVE tests, SELF-evaluation, MULTIVARIATE analysis, PREGNANT women, ACQUISITION of data, SURVEYS, DOCUMENTATION, DESCRIPTIVE statistics, MEDICAL records, RESEARCH funding, ELECTRONIC health records, VACCINATION status, DEMOGRAPHY, ODDS ratio, SENSITIVITY & specificity (Statistics), PROBABILITY theory
Abstract

Objectives: Having accurate influenza vaccination coverage estimates can guide public health activities. The objectives of this study were to (1) validate the accuracy of electronic health record (EHR)–based influenza vaccination data among pregnant women compared with survey self-report and (2) assess whether survey respondents differed from survey nonrespondents by demographic characteristics and EHR-based vaccination status. Methods: This study was conducted in the Vaccine Safety Datalink, a network of 8 large medical care organizations in the United States. Using EHR data, we identified all women pregnant during the 2018-2019 or 2019-2020 influenza seasons. Surveys were conducted among samples of women who did and did not appear vaccinated for influenza according to EHR data. Separate surveys were conducted after each influenza season, and respondents reported their influenza vaccination status. Analyses accounted for the stratified design, sampling probability, and response probability. Results: The survey response rate was 50.5% (630 of 1247) for 2018-2019 and 41.2% (721 of 1748) for 2019-2020. In multivariable analyses combining both survey years, non-Hispanic Black pregnant women had 3.80 (95% CI, 2.13-6.74) times the adjusted odds of survey nonresponse; odds of nonresponse were also higher for Hispanic pregnant women and women who had not received (per EHR data) influenza vaccine during current or prior influenza seasons. The sensitivity, specificity, and positive predictive value of EHR documentation of influenza vaccination compared with self-report were ≥92% for both survey years combined. The negative predictive value of EHR-based influenza vaccine status was 80.5% (95% CI, 76.7%-84.0%). Conclusions: EHR-based influenza vaccination data among pregnant women were generally concordant with self-report. New data sources and novel approaches to mitigating nonresponse bias may be needed to enhance influenza vaccination surveillance efforts. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

141. Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.

Author

DeSilva, Malini B, Mitchell, Patrick K, Klein, Nicola P, Dixon, Brian E, Tenforde, Mark W, Thompson, Mark G, Naleway, Allison L, Grannis, Shaun J, Ong, Toan C, Natarajan, Karthik, Reese, Sarah E, Zerbo, Ousseny, Kharbanda, Anupam B, Patel, Palak, Stenehjem, Edward, Raiyani, Chandni, Irving, Stephanie A, Fadel, William F, Rao, Suchitra, and Han, Jungmi

Subjects
SARS-CoV-2, CORONAVIRUS diseases, COVID-19
Abstract

Background: We assessed COVID-19 vaccination impact on illness severity among adults hospitalized with COVID-19 August 2021-March 2022.Methods: We evaluated differences in intensive care unit (ICU) admission, in-hospital death, and length of stay among vaccinated (2 or 3 mRNA vaccine doses) versus unvaccinated patients aged ≥18 years hospitalized for ≥24 hours with COVID-19-like illness (CLI) and positive SARS-CoV-2 molecular testing. We calculated odds ratios for ICU admission and death and subdistribution hazard ratios (SHR) for time to hospital discharge adjusted for age, geographic region, calendar time, and local virus circulation.Results: We included 27,149 SARS-CoV-2 positive hospitalizations. During both Delta and Omicron-predominant periods, protection against ICU admission was strongest among 3-dose vaccinees compared with unvaccinated patients (Delta OR [CI]: 0.52 [0.28-0.96]); Omicron OR [CI]: 0.69 [0.54-0.87]). During both periods, risk of in-hospital of death was lower among vaccinated compared with unvaccinated but ORs were overlapping; during Omicron, lowest among 3-dose vaccinees (OR [CI] 0.39 [0.28-0.54]). We observed SHR >1 across all vaccination strata in both periods indicating faster discharge for vaccinated patients.Conclusions: COVID-19 vaccination was associated with lower rates of ICU admission and in-hospital death in both Delta and Omicron periods compared with being unvaccinated. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

142. Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.

Author

Simões, Eric A F, Klein, Nicola P, Sabharwal, Charu, Gurtman, Alejandra, Kitchin, Nicholas, Ukkonen, Benita, Korbal, Piotr, Zou, Jing, Xie, Xuping, Sarwar, Uzma N, Xu, Xia, Lockhart, Stephen, Cunliffe, Luke, Lu, Claire, Ma, Hua, Swanson, Kena A, Koury, Kenneth, Shi, Pei-Yong, Cooper, David, and Türeci, Ӧzlem

Subjects
*IMMUNOGLOBULINS, *CONFIDENCE intervals, *COVID-19 vaccines, *VACCINE immunogenicity, *BLOOD collection, *LYMPHATIC diseases, *MESSENGER RNA, *RESEARCH funding, *DESCRIPTIVE statistics, *NEUTRALIZATION tests, *LONGITUDINAL method, *CHILDREN
Abstract

In this ongoing study, substantially increased ancestral SARS-CoV-2 neutralizing responses were observed 1 month after a third 10-µg BNT162b2 dose given to 5 to 11-year olds versus neutralizing responses post-dose 2. After dose 3, increased neutralizing responses against Omicron BA.1 and BA.4/BA.5 strains were also observed. The safety/tolerability profile was acceptable. (NCT04816643) [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

144. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

Author

Moreira, Edson D., primary, Kitchin, Nicholas, additional, Xu, Xia, additional, Dychter, Samuel S., additional, Lockhart, Stephen, additional, Gurtman, Alejandra, additional, Perez, John L., additional, Zerbini, Cristiano, additional, Dever, Michael E., additional, Jennings, Timothy W., additional, Brandon, Donald M., additional, Cannon, Kevin D., additional, Koren, Michael J., additional, Denham, Douglas S., additional, Berhe, Mezgebe, additional, Fitz-Patrick, David, additional, Hammitt, Laura L., additional, Klein, Nicola P., additional, Nell, Haylene, additional, Keep, Georgina, additional, Wang, Xingbin, additional, Koury, Kenneth, additional, Swanson, Kena A., additional, Cooper, David, additional, Lu, Claire, additional, Türeci, Özlem, additional, Lagkadinou, Eleni, additional, Tresnan, Dina B., additional, Dormitzer, Philip R., additional, Şahin, Uğur, additional, Gruber, William C., additional, and Jansen, Kathrin U., additional

Published
2022
Full Text
View/download PDF

146. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

Author

Hanson, Kayla E., primary, Goddard, Kristin, additional, Lewis, Ned, additional, Fireman, Bruce, additional, Myers, Tanya R., additional, Bakshi, Nandini, additional, Weintraub, Eric, additional, Donahue, James G., additional, Nelson, Jennifer C., additional, Xu, Stan, additional, Glanz, Jason M., additional, Williams, Joshua T. B., additional, Alpern, Jonathan D., additional, and Klein, Nicola P., additional

Published
2022
Full Text
View/download PDF

147. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022

Author

Natarajan, Karthik, primary, Prasad, Namrata, additional, Dascomb, Kristin, additional, Irving, Stephanie A., additional, Yang, Duck-Hye, additional, Gaglani, Manjusha, additional, Klein, Nicola P., additional, DeSilva, Malini B., additional, Ong, Toan C., additional, Grannis, Shaun J., additional, Stenehjem, Edward, additional, Link-Gelles, Ruth, additional, Rowley, Elizabeth A., additional, Naleway, Allison L., additional, Han, Jungmi, additional, Raiyani, Chandni, additional, Benitez, Gabriela Vazquez, additional, Rao, Suchitra, additional, Lewis, Ned, additional, Fadel, William F., additional, Grisel, Nancy, additional, Griggs, Eric P., additional, Dunne, Margaret M., additional, Stockwell, Melissa S., additional, Mamawala, Mufaddal, additional, McEvoy, Charlene, additional, Barron, Michelle A., additional, Goddard, Kristin, additional, Valvi, Nimish R., additional, Arndorfer, Julie, additional, Patel, Palak, additional, Mitchell, Patrick K, additional, Smith, Michael, additional, Kharbanda, Anupam B., additional, Fireman, Bruce, additional, Embi, Peter J., additional, Dickerson, Monica, additional, Davis, Jonathan M., additional, Zerbo, Ousseny, additional, Dalton, Alexandra F., additional, Wondimu, Mehiret H., additional, Azziz-Baumgartner, Eduardo, additional, Bozio, Catherine H., additional, Reynolds, Sue, additional, Ferdinands, Jill, additional, Williams, Jeremiah, additional, Schrag, Stephanie J., additional, Verani, Jennifer R., additional, Ball, Sarah, additional, Thompson, Mark G., additional, and Dixon, Brian E., additional

Published
2022
Full Text
View/download PDF

148. Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015–2017

Author

Lewis, Rayleen M., primary, Naleway, Allison L., additional, Klein, Nicola P., additional, Crane, Bradley, additional, Hsiao, Amber, additional, Aukes, Laurie, additional, Timbol, Julius, additional, Querec, Troy D., additional, Steinau, Martin, additional, Weinmann, Sheila, additional, Unger, Elizabeth R., additional, and Markowitz, Lauri E., additional

Published
2022
Full Text
View/download PDF

149. Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders

Author

Zerbo, Ousseny, primary, Modaressi, Sharareh, additional, Goddard, Kristin, additional, Lewis, Edwin, additional, Fireman, Bruce, additional, Daley, Matthew F., additional, Irving, Stephanie A., additional, Jackson, Lisa A., additional, Donahue, James G., additional, Qian, Lei, additional, Getahun, Darios, additional, DeStefano, Frank, additional, McNeil, Michael M., additional, and Klein, Nicola P., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results